Tepoxalin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 52: | Line 52: | ||
| StdInChI = 1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3 | | StdInChI = 1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3 | ||
| StdInChIKey = XYKWNRUXCOIMFZ-UHFFFAOYSA-N | | StdInChIKey = XYKWNRUXCOIMFZ-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
| Line 59: | Line 58: | ||
==Overview== | ==Overview== | ||
'''Tepoxalin''' is a [[nonsteroidal anti-inflammatory drug]] approved for veterinary use in the United States and many other countries.<ref name="drugsdotcom">http://www.drugs.com/international/tepoxalin.html</ref> It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as [[hip dysplasia (canine)|hip dysplasia]] and [[arthritis]].<ref>http://www.peteducation.com/article.cfm?c=26+1303&aid=3213</ref> | '''Tepoxalin''' is a [[nonsteroidal anti-inflammatory drug]] approved for veterinary use in the United States and many other countries.<ref name="drugsdotcom">http://www.drugs.com/international/tepoxalin.html</ref> It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as [[hip dysplasia (canine)|hip dysplasia]] and [[arthritis]].<ref>http://www.peteducation.com/article.cfm?c=26+1303&aid=3213</ref> | ||
It is generally marketed under the brand name '''Zubrin'''.<ref name="drugsdotcom"/> | It is generally marketed under the brand name '''Zubrin'''.<ref name="drugsdotcom"/> | ||
==See also== | ==See also== | ||
*[[Ipazilide]] | *[[Ipazilide]] | ||
Revision as of 19:22, 6 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H20ClN3O3 |
| Molar mass | 385.844 g/mol |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Tepoxalin |
|
Articles |
|---|
|
Most recent articles on Tepoxalin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tepoxalin at Clinical Trials.gov Clinical Trials on Tepoxalin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tepoxalin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tepoxalin Discussion groups on Tepoxalin Directions to Hospitals Treating Tepoxalin Risk calculators and risk factors for Tepoxalin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tepoxalin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and many other countries.[1] It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.[2] It is generally marketed under the brand name Zubrin.[1]
See also
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Dog health
- Pyrazoles
- Hydroxamic acids
- Non-steroidal anti-inflammatory drugs
- Phenol ethers
- Organochlorides
- Drug